4.8 Article

Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38

期刊

SCIENCE
卷 318, 期 5852, 页码 977-980

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1147379

关键词

-

资金

  1. NCI NIH HHS [R01 CA129821] Funding Source: Medline
  2. NIGMS NIH HHS [R01 GM068832, GM068832] Funding Source: Medline

向作者/读者索取更多资源

The mammalian target of rapamycin, mTOR, is a central regulator of cell growth. Its activity is regulated by Rheb, a Ras-like small guanosine triphosphatase ( GTPase), in response to growth factor stimulation and nutrient availability. We show that Rheb regulates mTOR through FKBP38, a member of the FK506-binding protein ( FKBP) family that is structurally related to FKBP12. FKBP38 binds to mTOR and inhibits its activity in a manner similar to that of the FKBP12-rapamycin complex. Rheb interacts directly with FKBP38 and prevents its association with mTOR in a guanosine 5'-triphosphate (GTP)-dependent manner. Our findings suggest that FKBP38 is an endogenous inhibitor of mTOR, whose inhibitory activity is antagonized by Rheb in response to growth factor stimulation and nutrient availability.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据